Release – Great Bear Resources (GTBAF) – Doubles Vertical Extent of LP Fault Intersects High-Grade Gold


Great Bear Doubles Vertical Extent of LP Fault, Intersects High-Grade Gold at
942.20 m Downhole: 15.57 g/t Gold Over 3.05 m

 

March 29, 2021 – Vancouver, British Columbia,
Canada
– Great Bear Resources Ltd. (the “Company” or “Great Bear”, TSX-V: GBR; OTCQX: GTBAF) today reported results from its ongoing fully funded $45 million 2021 exploration program at its 100% owned flagship Dixie Project in the Red Lake district of Ontario.

Expansion of the LP
Fault

  • Deep drilling has doubled the
    drill-confirmed vertical extent
    of the LP Fault gold zone, which begins at bedrock surface, to approximately 800 vertical metres.  The area of ongoing grid drilling extends along 4 kilometres of strike length.  Figure 1 and Figure 2.
  • Three new 400 – 450 metre step-down holes drilled along 500
    metres of strike length all
    successfully intersected the continuation
    of the LP Fault host rocks and gold mineralization at depths of 700 – 820
    vertical metres
    .
  • Gold grades and mineralized
    zone thickness were better at depth
    on two of three tested drill sections.
  • Initial deep drilling tested below the most weakly
    mineralized segment
    of the LP Fault, formerly referred to as the “Gap” zone (February 13, 2020).
  • Large scale step-out drilling at depth,
    including below areas
    of high-grade gold mineralization
    , will continue throughout 2021.

High-Grade Gold in the First Deep LP Fault
Drill Holes

  • High-grade gold was intersected at depth in two of the three deep drill holes, with better grades and thickness than previously observed in the near surface.  All three deep drill holes contained multiple intervals of gold mineralization.  Table 1 and Table 2.
  • BR-260 is the deepest LP Fault drill hole to date.  It assayed 15.57
    g/t gold over 3.05 metres
    from 942.20 to 945.25 metres, within a broader interval of 1.08
    g/t gold over 70.25 metres
    from 906.15 to 976.40 metres.  Figure
    3
    and Figure
    4
    .
  • While high-grade intervals are the primary drill targets at these depths, the dual high-grade and bulk-tonnage character of the
    LP Fault gold zone remains strongly developed at depth
    .
  • Oriented core data collected from these initial deep holes will assist with determining controls to higher grade panels within the broad envelope of gold mineralization. 

Great Bear has now published results from 270 LP Fault drill holes and anticipates at least
130 additional
LP Fault drill holes will be completed by the end of 2021, for a total of at
least 400 drill holes
.

Chris Taylor, President and CEO of Great Bear said, “We drilled below the most weakly mineralized segment of the LP Fault with our first deep holes, and discovered better gold mineralization at depth.  After 270 drill holes we have yet to find the limits of the LP Fault’s gold mineralization.  Mesothermal gold systems of this type, particularly in the Red Lake area, can extend vertically over kilometres.  We are currently working with in-house and external modelers to finalize 2021 drill plans, and will provide guidance over the coming weeks on expected timing of delivery of initial estimates of mineral resources.”

Figure 1 (Top): Long section of the LP Fault zone showing the locations and depths of the new deep drill holes (labeled).
Figure 2 (Bottom) : Map of current drill results showing the location of the new deep drill holes.

 

 

Table 1: Drill holes released to date on section 21450 showing increased gold mineralization grades and widths with increasing depth in the former “Gap” zone.  See news releases of April 9, 2020 and May 4, 2020 for previously reported drill holes.
New results
from BR-260 in italics
.

Drill Hole

 

From (m)

To (m)

Width* (m)

Gold (g/t)

Vertical Depth (m)

BR-078

 

176.00

212.90

36.90

0.42

150

BR-097

 

255.00

259.00

4.00

1.39

220

 

and

391.70

393.50

1.80

3.49

335

BR-098

 

419.70

448.50

28.80

0.65

365

 

and

493.25

495.05

1.80

9.90

425

BR-260

 

906.15

976.40

70.25

1.08

760

(new)

including

942.20

945.25

3.05

15.57

790

* Widths are drill indicated core length, as insufficient drilling has been undertaken to determine true widths at this time.  Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts.  Interval widths are calculated using a 0.10 g/t gold cut-off grade with up to 3 m of internal dilution of zero grade. 

Table 2: New drill results from the first three deep holes into the LP Fault system along 500 metres of strike length in the “Gap” area.

Drill Hole

 

From (m)

To (m)

Width* (m)

Gold (g/t)

Section

BR-260

 

906.15

976.40

70.25

1.08

21450

 

including

929.30

948.00

18.70

3.33

 

 

and including

929.30

929.80

0.50

16.50

 

 

and including

942.20

945.25

3.05

15.57

 

 

and including

942.20

942.80

0.60

73.10

 

BR-261

 

624.85

638.50

13.65

0.57

21200

 

 

747.15

761.00

13.85

0.44

 

 

 

811.60

823.25

11.65

0.96

 

 

including

822.00

823.25

1.25

5.62

 

 

and

835.00

839.50

4.50

1.17

 

BR-262

 

871.00

876.50

5.50

1.19

21700

 

and

933.50

950.50

17.00

1.04

 

 

including

946.50

948.50

2.00

7.27

 

 

and including

946.50

947.50

1.00

12.30

 

* Widths are drill indicated core length, as insufficient drilling has been undertaken to determine true widths at this time.  Average grades are calculated with un-capped gold assays, as insufficient drilling has been completed to determine capping levels for higher grade gold intercepts.  Interval widths are calculated using a 0.10 g/t gold cut-off grade with up to 3 m of internal dilution of zero grade. 

Figure 3: Section 21450 showing BR-260, the deepest drill hole in the LP Fault to date.  This section is located in what was formerly referred to as the “Gap” zone.

 

 

Figure 4:  The deepest drill hole in the LP Fault to date.  73.10 g/t gold over 0.60 metres at 942.20 metres down hole in BR-260 (790 metres vertical depth).  The shear-zone hosted disseminated high-grade gold with sparse accessory sulphides within a felsic volcanic host matches mineralization at shallower depths within the LP Fault.  Image is of a selected interval and is not representative of all gold mineralization on the property.

 

 

Great Bear’s progress can be followed using the Company’s plan maps, long sections and cross sections, and through the VRIFY model posted at the Company’s web site at www.greatbearresources.ca, which will next be updated in Q2 2021.  All LP Fault drill hole highlighted assays, plus drill collar locations and orientations can also be downloaded at the Company’s web site.

Drill collar location, azimuth and dip for drill holes included in this release are provided in the table below (UTM zone 15N, NAD 83):

Hole
ID

Easting

Northing

Elevation

Length

Dip

Azimuth

BR-260

456566

5635016

372

1200

-64

225

BR-261

456714

5634887

364

1284

-63

220

BR-262

456384

5635181

378

1110

-63

224

 

About the Dixie Project

The Dixie Project is 100% owned, comprised of 9,140 hectares of contiguous claims that extend over 22 kilometres, and is located approximately 25 kilometres southeast of the town of Red Lake, Ontario. The project is accessible year-round via a 15 minute drive on a paved highway which runs the length of the northern claim boundary and a network of well-maintained logging roads.

The Dixie Project hosts two principal styles of gold mineralization:

  • High-grade gold in quartz veins
    and silica-sulphide replacement zones (Dixie Limb, Hinge and Arrow zones)
    . Hosted by mafic volcanic rocks and localized near regional-scale D2 fold axes.  These mineralization styles are also typical of the significant mined deposits of the Red Lake district.
  • High-grade disseminated gold
    with broad moderate to lower grade envelopes (LP Fault).
      The LP Fault is a significant gold-hosting structure which has been seismically imaged to extend to 14 kilometres depth (Zeng and Calvert, 2006), and has been interpreted by Great Bear to have up to 18 kilometres of strike length on the Dixie property.  High-grade gold mineralization is controlled by structural and geological contacts, and moderate to lower-grade disseminated gold surrounds and flanks the high-grade intervals.  The dominant gold-hosting stratigraphy consists of felsic sediments and volcanic units.

About Great Bear

Great Bear Resources Ltd.
is a well-financed gold exploration company managed by a team with a track record of success in mineral exploration.  Great Bear is focused in the prolific Red Lake gold district in northwest Ontario, where the company controls over 330 km2 of highly prospective tenure across 5 projects: the flagship Dixie Project (100% owned), the Pakwash Property (earning a 100% interest), the Dedee Property (earning a 100% interest), the Sobel Property (earning a 100% interest), and the Red Lake North Property (earning a 100% interest) all of which are accessible year-round through existing roads.

QA/QC and Core Sampling
Protocols

Drill core is logged and sampled in a secure core storage facility located in Red Lake Ontario.  Core samples from the program are cut in half, using a diamond cutting saw, and are sent to Activation Laboratories in Ontario, an accredited mineral analysis laboratory, for analysis. All samples are analysed for gold using standard Fire Assay-AA techniques. Samples returning over 10.0 g/t gold are analysed utilizing standard Fire Assay-Gravimetric methods.  Pulps from approximately 5% of the gold mineralized samples are submitted for check analysis to a second lab.  Selected samples are also chosen for duplicate assay from the coarse reject of the original sample.  Selected samples with visible gold are also analyzed with a standard 1 kg metallic screen fire assay.  Certified gold reference standards, blanks and field duplicates are routinely inserted into the sample stream, as part of Great Bear’s quality control/quality assurance program (QAQC).  No QAQC issues were noted with the results reported herein. 

Qualified Person and NI
43-101 Disclosure

Mr. R. Bob Singh, P.Geo, VP Exploration, and Ms. Andrea Diakow P.Geo, Exploration Manager for Great Bear are the Qualified Persons as defined by National Instrument 43-101 responsible for the accuracy of technical information contained in this news release.

ON BEHALF OF THE BOARD

“Chris Taylor”

Chris Taylor, President and CEO

Investor Inquiries:
Mr. Knox Henderson
Tel: 604-646-8354
Direct: 604-551-2360
info@greatbearresources.ca
www.greatbearresources.ca

Cautionary note regarding forward-looking statements

This release contains certain “forward looking statements” and
certain “forward-looking information” as defined under applicable Canadian and
U.S. securities laws. Forward-looking statements and information can generally
be identified by the use of forward-looking terminology such as “may”, “will”,
“should”, “expect”, “intend”, “estimate”, “anticipate”, “believe”, “continue”,
“plans” or similar terminology. The forward-looking information contained
herein is provided for the purpose of assisting readers in understanding
management’s current expectations and plans relating to the future. Readers are
cautioned that such information may not be appropriate for other purposes.

Forward-looking statements and information include, but are not
limited to, statements in respect of the proposed Offering including the
proposed use of proceeds, the closing date of the Offering, receipt of
regulatory and stock exchange approvals, the timing of future drilling,
exploration and budgets.

Forward-looking information are based on management of the
parties’ reasonable assumptions, estimates, expectations, analyses and
opinions, which are based on such management’s experience and perception of trends,
current conditions and expected developments, and other factors that management
believes are relevant and reasonable in the circumstances, but which may prove
to be incorrect.

Such factors, among other things, include: impacts arising from
the global disruption caused by the Covid-19 coronavirus outbreak, business
integration risks; fluctuations in general macroeconomic conditions;
fluctuations in securities markets; fluctuations in spot and forward prices of
gold or certain other commodities; change in national and local government,
legislation, taxation, controls, regulations and political or economic
developments; risks and hazards associated with the business of mineral
exploration, development and mining (including environmental hazards, industrial
accidents, unusual or unexpected formations pressures, cave-ins and flooding);
discrepancies between actual and estimated metallurgical recoveries; inability
to obtain adequate insurance to cover risks and hazards; the presence of laws
and regulations that may impose restrictions on mining; employee relations;
relationships with and claims by local communities and indigenous populations;
availability of increasing costs associated with mining inputs and labour; the
speculative nature of mineral exploration and development (including the risks
of obtaining necessary licenses, permits and approvals from government
authorities); and title to properties.

Great Bear undertakes
no obligation to update forward-looking information except as required by
applicable law. Such forward-looking information represents management’s best
judgment based on information currently available. No forward-looking statement
can be guaranteed and actual future results may vary materially. Accordingly,
readers are advised not to place undue reliance on forward-looking statements
or information

Helius Medical Technologies (HSDT)(HSM:CA) – FDA Approval of PoNS for MS

Monday, March 29, 2021

Helius Medical Technologies (HSDT)(HSM:CA)
FDA Approval of PoNS for MS

Helius Medical Technologies Inc are a medical technology company. It is focused on the development of products for the treatment of neurological symptoms caused by disease or trauma. The company has developed its first, known as the portable neuromodulation stimulator or PoNS, device, is designed to enhance the brain’s ability to compensate for this damage.

Joe Gomes, Senior Research Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

    FDA Approval. On Friday, the U.S. Food and Drug Administration authorized marketing of the PoNS device for use as a short-term treatment of gait deficit due to mild to moderate symptoms from multiple sclerosis (MS). The device is intended to be used by prescription only as an adjunct to a supervised therapeutic exercise program in patients 22 years of age and older. With over one million MS patients in the U.S., this is the largest market for which the PoNS treatment has received approval.

    FDA Comment.  According to Christopher M. Loftus, M.D., acting director of the Office of Neurological and Physical Medicine Devices in the FDA’s Center for Devices and Radiological Health, “MS is one of the most common neurological diseases in young adults. Today’s authorization offers a valuable new aid in physical therapy and increases the value of additional therapies for those who live with MS …



This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary.  Proper due diligence is required before making any investment decision. 

Release – Lineage Cell Therapeutics (LCTX) – Vitelliform Maculopathy Patient Treated With OpRegen Under Named Patient Compassionate Use

 


Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use

 

CARLSBAD, Calif.–(BUSINESS WIRE)–Mar. 29, 2021–

Lineage Cell Therapeutics, Inc.

(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medical conditions, today announced that a patient suffering from adult-onset vitelliform macular dystrophy (AVMD) had recently been treated with its lead product candidate, OpRegen, at
Hadassah-Hebrew University Medical Center in
Jerusalem, using a named patient compassionate use approval granted by the
Israeli Ministry of Health. OpRegen is an investigational cell therapy consisting of allogeneic retinal pigment epithelium (RPE) cells administered to the subretinal space and is currently being investigated in a 24-patient phase 1/2a clinical trial for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA).

“Lineage is pioneering a new branch of medicine, consisting of the directed differentiation and transplant of specific cell types to replace damaged or dying cells with the goal of restoring or improving function lost to injury or disease,” stated Brian M. Culley, Lineage CEO. “With OpRegen, we are transplanting new retina cells to replace old cells that were lost or damaged to disease, with a goal of providing stability or functional improvements to vision. As outlined more fully on our recent earnings call, we believe there are many potential applications of Lineage’s core technology and intend this year to demonstrate that although we currently have three clinical-stage product candidates, those assets and our underlying platform may have utility in additional settings. For example, our RPE cells may be useful for treating additional retinal diseases, such as AVMD or Stargardt’s Disease. Similarly, our spinal cord program may be applicable to other conditions characterized by demyelination, and our oncology platform may have application across many different tumor types, depending on which antigen we elect to present to the patient’s immune system.”

Mr. Culley continued, “In this first instance, we treated a patient with AVMD, because it closely resembles dry AMD and similarly involves impaired RPE function and progressive vision loss. When the team at Hadassah approached us about treating their existing AVMD patient with OpRegen on a compassionate use basis, we were supportive of the request and saw it as an opportunity to investigate a new application for our OpRegen product candidate.”

This patient presented to the
Department of Ophthalmology at
Hadassah-Hebrew University Medical Center in late
December 2020 with sudden and severe visual acuity decreases in one eye. BCVA in the worse vision eye was measured at 20/200, compared to 20/40 in the patient’s contralateral eye. After an onset of blurred vision in 2018, evaluation and imaging diagnosed the patient as suffering from AVMD. Because AVMD is a disease of impaired RPE function leading to atrophy and shares similar characteristics to dry AMD, the team at Hadassah approached Lineage about the potential to treat this patient on a compassionate use basis. Lineage submitted a request on behalf of
Hadassah-Hebrew University Medical Center which was approved by the
Israeli Ministry of Health. Following approval from the University’s Ethics Committee, the patient was treated in
February 2021. The delivery of OpRegen RPE cells via pars plana vitrectomy was successful, with no complications arising during the procedure and the patient remains in follow-up.

About Adult-onset Vitelliform Maculopathy (AVMD)

AVMD is an eye disorder that can cause progressive vision loss and usually begins after age 40. AVMD affects an area of the retina called the macula, which is responsible for sharp central vision. The condition causes a fatty yellow pigment to accumulate in cells underlying the macula, eventually damaging the cells. Some people remain without symptoms throughout their life while others may slowly develop blurred and/or distorted vision, that can progress to central vision loss over time. There is currently no effective treatment for vitelliform macular dystrophy.

About OpRegen

OpRegen is currently being evaluated in a Phase 1/2a open-label, dose escalation safety and efficacy study of a single injection of human retinal pigment epithelium cells derived from an established pluripotent cell line and transplanted subretinally in patients with advanced dry AMD with GA. The study enrolled 24 patients into 4 cohorts. The first 3 cohorts enrolled only legally blind patients with best corrected visual acuity (BCVA) of 20/200 or worse. The fourth cohort enrolled 12 better vision patients (vision from 20/65 to 20/250 with smaller areas of GA). Cohort 4 also included patients treated with a new “thaw-and-inject” formulation of OpRegen, which can be shipped directly to sites and used immediately upon thawing, removing the complications and logistics of having to use a dose preparation facility. The primary objective of the study is to evaluate the safety and tolerability of OpRegen as assessed by the incidence and frequency of treatment emergent adverse events. Secondary objectives are to evaluate the preliminary efficacy of OpRegen treatment by assessing the changes in ophthalmological parameters measured by various methods of primary clinical relevance. OpRegen is a registered trademark of
Cell Cure Neurosciences Ltd., a majority-owned subsidiary of
Lineage Cell Therapeutics, Inc.

About Lineage Cell Therapeutics, Inc. 

Lineage Cell Therapeutics
is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include three allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit
www.lineagecell.com or follow the Company on Twitter @LineageCell.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” project,” “target,” “tend to,” or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to the potential conditions and diseases applicable to Lineage’s clinical-stage product candidates. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineage’s business and other risks in Lineage’s filings with the
Securities and Exchange Commission (SEC). Lineage’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading “Risk Factors” in Lineage’s periodic reports with the
SEC, including Lineage’s most recent Annual Report on Form 10-K filed with the
SEC
and its other reports, which are available from the SEC’s website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Lineage Cell Therapeutics, Inc. IR
Ioana C. Hone
(ir@lineagecell.com)
(442) 287-8963

Solebury Trout IR
Gitanjali Jain Ogawa
(Gogawa@troutgroup.com)
(646) 378-2949

Russo Partners – Media Relations
Nic Johnson or David Schull
Nic.johnson@russopartnersllc.com
David.schull@russopartnersllc.com
(212) 845-4242

Source: Lineage Cell Therapeutics, Inc.

Research coverage of Lineage Cell Therapeutics (LCTX) on Channelchek is provided by Noble Capital Markets, Inc. Please refer to the research disclosures on the most recent LCTX report for more information.

Is There Opportunity in the Suez Predicament?

 


Is There Opportunity in the Suez Predicament?

 

Just shy of a week after its becoming lodged in the Suez Canal, teams have made some progress on the 1,300-foot ship owned by the Taiwanese company Evergreen Marine Corp. This has brought needed hope that the busy trade route could soon reopen. Clearing the stranded ship would help take its owners out of what has been a harsh global reaction. And it’s no wonder why it has been so pointed; although the shipping industry is expected to recover from the Suez incident, shipping is considered one of the important post-pandemic recovery sectors as global commerce builds to a more normal pace. The industry had a nightmarish 2020, that was coming to an end. In fact, two weeks before the ships grounding on March 23rd, many shipping companies began to rally, outperforming the S&P 500. They have dipped since the mishap. This dip may open an opportunity for investors that missed the initial run. 

Notable companies whose research is available here on Channelchek are Pyxis Tankers (PXS) up 5.56% over the past month. Seanergy (SHIP) is off its highs but still up 7.44%, Genco Shipping (GNK) is up 9.18% after this incident, Grindrod Shipping (GRIN) 10.44%, Euroseas (ESEA) is down from its 2021 peak on March 15th but still up a sizeable 26.69% on the month, and Eurodry’s (EDRY) ascent seems to have slowed with a current gain of 24.83% month over month.

 

 

The below info-graphic provided by Visual
Capitalist
shows the disruption this temporary event has on global shipping as 12% of all physical global trade passes through the Suez Canal.

 

 

Feel free to share this information.

Questions/comments can be directed to the Channelchek Team.

 

Related Investor Information:


NobleCon17 Transportation Panel Video

D


Why Oil Prices Can Continue Going Up


FT – Is There Opportunity in the Suez Predicament?

 


Is There Opportunity in the Suez Predicament?

 

Just shy of a week after its becoming lodged in the Suez Canal, teams have made some progress on the 1,300-foot ship owned by the Taiwanese company Evergreen Marine Corp. This has brought needed hope that the busy trade route could soon reopen. Clearing the stranded ship would help take its owners out of what has been a harsh global reaction. And it’s no wonder why it has been so pointed; although the shipping industry is expected to recover from the Suez incident, shipping is considered one of the important post-pandemic recovery sectors as global commerce builds to a more normal pace. The industry had a nightmarish 2020, that was coming to an end. In fact, two weeks before the ships grounding on March 23rd, many shipping companies began to rally, outperforming the S&P 500. They have dipped since the mishap. This dip may open an opportunity for investors that missed the initial run. 

Notable companies whose research is available here on Channelchek are Pyxis Tankers (PXS) up 5.56% over the past month. Seanergy (SHIP) is off its highs but still up 7.44%, Genco Shipping (GNK) is up 9.18% after this incident, Grindrod Shipping (GRIN) 10.44%, Euroseas (ESEA) is down from its 2021 peak on March 15th but still up a sizeable 26.69% on the month, and Eurodry’s (EDRY) ascent seems to have slowed with a current gain of 24.83% month over month.

 

 

The below info-graphic provided by Visual
Capitalist
shows the disruption this temporary event has on global shipping as 12% of all physical global trade passes through the Suez Canal.

 

 

Feel free to share this information.

Questions/comments can be directed to the Channelchek Team.

 

Related Investor Information:


NobleCon17 Transportation Panel Video

D


Why Oil Prices Can Continue Going Up


QuickChek – March 29, 2021



Salem Podcast Network Announces Partnership with The Todd Starnes Podcast

Salem Media Group announced that the Todd Starnes Podcast has been added to the Salem Podcast Network

Research, News & Market Data on Salem Media Group

Watch recent presentation from NobleCon17



Entravision Launches Fuego Radio Format in the Las Vegas and Palm Springs Markets

Entravision Communications announced that its Fuego Radio format is expanding into two new owned and operated stations in the Las Vegas and Palm Springs markets

Research, News & Market Data on Entravision Communications

Watch recent presentation from NobleCon17



Great Bear Doubles Vertical Extent of LP Fault, Intersects High-Grade Gold

Great Bear Resources announced results from its ongoing fully funded $45 million 2021 exploration program at its 100% owned flagship Dixie Project in the Red Lake district of Ontario.

News & Market Data on Great Bear Resources

Watch recent presentation from NobleCon17



Bunker Hill Mining Reports Multiple High-Grade Silver Mineralization Results

Bunker Hill Mining announced multiple high-grade silver mineralization results as part of its ongoing silver-focused drilling program

News & Market Data on Bunker Hill Mining



Is There Opportunity in the Suez Predicament?

Shipping is considered one of the important post-pandemic recovery sectors as global commerce builds to a more normal pace

Read More



Kratos’ Autonomous Truck-Mounted Attenuator Named Infrastructure Game Changer by American Society of Civil Engineers

Kratos Defense & Security Solutions announced that its Autonomous Truck-Mounted Attenuator has been recognized by the American Society of Civil Engineers as an “Infrastructure Gamechanger” in the organization’s 2021 Report Card for American Infrastructure

Research, News & Market Data on Kratos Defense & Security Solutions

Watch interview with Kratos President and CEO Eric DeMarco



FDA Authorizes Marketing for Helius’ PoNS Device for Multiple Sclerosis Patients

Noble Capital Markets Senior Research Analyst Joe Gomes’ report

U.S. Food and Drug Administration’s press release

Research, News & Market Data on Helius Medical Technologies

Watch recent presentation from NobleCon17



Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen

Lineage Cell Therapeutics announced that a patient suffering from adult-onset vitelliform macular dystrophy (AVMD) had recently been treated with its lead product candidate, OpRegen

Research, News & Market Data on Lineage Cell Therapeutics

Watch recent presentation from NobleCon17

Stay up to date. Follow us:

Release – Entravision (EVC) – Launches Fuego Radio Format in the Las Vegas and Palm Springs Markets


Entravision Launches Fuego Radio Format in the Las Vegas and Palm Springs Markets

 

SANTA MONICA, Calif.–(BUSINESS WIRE)– Entravision Communications Corporation:

WHAT:

Entravision Communications Corporation (NYSE: EVC), a leading global media and marketing technology company, today announced its Fuego Radio format is expanding into two new owned and operated stations in the Las Vegas (92.7 FM) and Palm Springs (103.5 FM) markets beginning on March 29, 2021. This follows Fuego Radio’s expansion into the Santa Barbara-Santa Maria affiliate (97.1 FM) market on January 6, 2021.

 

 

 

Fuego Radio presents a music mix ignited by today’s top trending global Latin Urban music movement mixed with Contemporary Hits, including recent chart topping artists such as Ariana Grande, Dua Lupa, Cardi B, Olivia Rodrigo, Drake, The Weeknd and Bruno Mars. In addition to hit music offerings, each morning Fuego Radio listeners can enjoy the antics of Edgar “Shoboy” Sotelo, on the popular Shoboy Show. This feel-good entertainment experience is real, relatable and fun and targets young adults that prefer entertainment in English with a Latin vibe. The Shoboy Show is also featured on Fuego Stations in Sacramento, Stockton and Modesto, California, Albuquerque, New Mexico, Salt Lake City, Utah and Harlingen, Brownsville and McAllen, Texas.

 

 

WHERE:

KRTO-FM, Santa Barbara-Santa Maria — as of January 6, 2021

 

KRRN-FM, Las Vegas and KPST-FM, Palm Springs — as of March 29, 2021

 

 

QUOTE:

“Following the expansion of our popular Fuego Radio format into the Santa Barbara-Santa Maria market in January, we are thrilled to also introduce this format into the Las Vegas and Palm Springs markets,” said Entravision’s Nestor Rocha, Vice President of Audio. “The Shoboy Show has been a great success in all of our markets, and we anticipate this momentum to continue in Las Vegas and Palm Springs as well.”

 

Contact for Affiliation:
Marisol Rodriguez
marisolrodriguez@entravision.com
323-900-6310

Contact for Ad Sales:
Las Vegas:
Chris Jordan, SVP
cjordan@entravision.com
702-507-1047

Palm Springs:
Bob McCauley, SVP
bmccauley@entravision.com
760-797-8401

Contact for Entravision:
Kimberly Esterkin
ADDO Investor Relations
evc@addoir.com
310-829-5400

Source: Entravision Communications Corporation

Platinum and Palladium Pricing for the Foreseeable Future

 


Supply and Demand Fundamentals for Platinum and Palladium

 

What are Platinum Group Metals?

Platinum group metals include platinum, palladium, rhodium, ruthenium, osmium, and iridium. Efforts to reduce carbon-dioxide emissions are boosting demand for platinum group metals, including palladium and platinum, for use in autocatalysts. In 2020, platinum and palladium futures prices rose 11.1% and 28.4% to finish the year at $1,079.50 and $2,455.50 per ounce, respectively. Year-to-date through March 26, 2021, platinum futures prices increased 10.3% to $1,191.10 per ounce, while palladium futures prices increased 9.1% to $2,680.00 per ounce. Notably, palladium is experiencing a multi-year supply deficit. Palladium is mined primarily in Russia and South Africa and mostly extracted as a by-product from mining other metals, including platinum and nickel. Platinum’s share of the autocatalyst market has fallen over the last fifteen years due to the adoption of palladium-rhodium catalysts in most cars that use gasoline and a move away from diesel automobiles that use platinum. However, given the price differential, some switching may occur, although car manufacturers seem more focused on advancing electric vehicles than making changes to a catalytic converter’s cost. Most realize that such a switch is just likely to result in higher platinum prices, and the burdens of making the change may not be worth the cost savings.

Supply and Demand Fundamentals

Johnson Matthey, a global leader in sustainable technologies and the largest fabricator and recycler of platinum group metals, publishes a monthly supply and demand outlook for platinum group metals. The company recently formed a strategic partnership with Sibanye-Stillwater, a leading precious metals mining company, to identify and develop solutions to propel decarbonization and the more efficient use of critical metals such as platinum group metals and metals used in battery technology. The partnership is expected to support the development of technologies for new products and markets to underpin sustainable supply chains for a low carbon future, including hydrogen production and fuel cells.

Johnson Matthey expects supply and demand for platinum group metals to recover towards pre-pandemic levels during 2021, assuming COVID-19 disruption eases. With respect to demand, automotive platinum group metals demand is expected to increase 13%, reflecting a strong recovery in light vehicle production and the implementation of China VI legislation enforcing the use of platinum group metal catalysts on heavy-duty diesel trucks. Furthermore, industrial demand is expected to remain strong, with chemical manufacturers expected to reach record levels. Johnson Matthey expects the palladium and rhodium markets to remain in deficit, while the market balance for platinum may hinge on jewelry and investment demand. Additionally, platinum’s discount to gold may spur greater demand, along with greater use in gasoline autocatalysts and fuel cells.

The table below illustrates the supply and demand for platinum and palladium for the years 2018 through 2020.

 

 

What is evident from the table is that both metals are in supply deficit and that demand for palladium as a material for autocatalysts materially exceeds total supply. End-use markets are still largely dependent on supplies from South Africa and Russia for supplies, although for manufacturers of emissions control equipment, palladium supplies are more readily available from North American sources than platinum. Given the expected growth in demand and the long lead time for bringing new supply to the market, prices could remain strong for the foreseeable future.

Electric Vehicles Represent a Threat?

The evolution to carbon-free vehicles will likely take some time and investors should expect twists and turns when it comes to predicting the winning technology. For now, it seems that internal combustion engine vehicles may be with us for a while, along with hybrid vehicles, and both use palladium and platinum. Battery technology is making rapid advances, although the materials used in those batteries are likely to continue to evolve. What does seem likely is that due to the expected growth in demand for platinum group metals juxtaposed against limited sources of supply, pricing appears durable for the foreseeable future.

While metals associated with batteries for electric vehicles do not include palladium or platinum, demand for platinum could benefit from advancements in fuel cell technology. An interesting article in the Wall Street Journal raised the question of whether hydrogen fuel cells could become more mainstream as a low carbon power source for vehicles. Hydrogen fuel cell technology uses platinum, given its ability to withstand higher temperatures than other metals. According to the article, a fuel cell needs platinum for the catalyst that separates hydrogen into protons and electrons, which then generate the electrical current, making it an alternative to battery-powered vehicles. Of course, much like materials used for batteries, fuel cell companies will seek to hit on a combination of materials that optimize performance and lower cost, which may result in efforts to either reduce or eliminate the use of platinum in favor of lower-cost or more widely available materials. 

 

 

Take-Away

The supply and demand fundamentals for platinum group elements remain quite attractive. Large and high-grade deposits are becoming more difficult to find, particularly in favorable mining jurisdictions. As a result, new sources of palladium supply are needed to meet demand and help achieve stricter air quality standards.  Thinking more broadly, the long-term outlook for platinum group metals, along with battery metals such as cobalt, copper, lithium, and nickel demand remains favorable due to increasingly more stringent emissions standards and expected usage associated with the move toward electrification and clean energy technologies, including electric vehicles, solar power, and fuel cells.

More to Discover on Channelchek:

Interview with Palladium One Mining CEO Derrick Weyrauch

How Does Uranium Fit Into the ESG Energy Landscape?


Digging Deeper Into Gold Investments – Understanding Royalty Companies

Can Mining be Green and Sustainable?

Sources:

Johnson
Matthey and Sibanye-Stillwater form a Strategic Partnership to Secure Critical
Metals and Accelerate New Technologies for a Low Carbon Future
, Press Release, Johnson Matthey, March 19, 2021.

Pgm
Market Report
, Johnson Matthey, Alison Cowley et al., February 2021

Fuel
Cell Technology Lets Platinum Miners Shine Again
, The Wall Street Journal, Alexandra Wexler, March 25, 2021.

For
Hydrogen Fuel Cells, Mundane Materials Might be Almost as Good as Pricey
Platinum
, Princeton University, Office of Engineering Communications, Jen A. Miller, June 17, 2019.

New
Catalyst Resolves Hydrogen Fuel Cell Cost, Longevity Issues
, The Source, Washington University in St. Louis, December 3, 2020.

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Release – Bunker Hill Mining (BHLL)(BNKR:CA) – Reports Multiple High-Grade Silver Mineralization Results


Bunker Hill Announces 3.8 Meters at 997 Ag Eq g/t Drill Intercept, Ten Channel Samples Above 900 Ag Eq g/t Including 0.6 Meters at 3,003 Ag Eq

 

Bunker Hill Announces 3.8 Meters at 997 Ag Eq g/t Drill Intercept, Ten Channel Samples Above 900 Ag Eq g/t Including 0.6 Meters at 3,003 Ag Eq

Bunker Hill to Host a Webinar on Wednesday, March 31 @ 8:00am PT/11:00am ET

HIGHLIGHTS:

  • Ten
    separate high-grade silver mineralization results greater than 900 g/t
    AgEq 1 , each with minimum 0.6m length, identified through targeted
    chip-channel sampling in newly accessible part of 9-level Deadwood vein
    • Best
      selected chip sample includes 0.6m at 1,100 g/t Ag and 60% Pb,
      representing 3,002.6 g/t AgEq 1
    • Mineralization
      remains open up dip, down dip and along strike from the sampling location
    • Follow-up
      diamond drilling is planned to test the extent of the Deadwood vein and
      nearby Jersey vein
  • High-grade
    silver, lead and zinc mineralization, including 3.8m at 197 g/t Ag, 21.2%
    Pb and 2.7% Zn, representing 996.6 g/t AgEq 1 , intersected at
    down-dip extension of the UTZ zone at the 5-level
  • Executive
    Chairman Richard Williams, CEO Sam Ash, and CFO David Wiens to host live
    interactive 6ix virtual investor event on Wednesday, March 31st at 11:00AM
    ET / 8:00AM PT to discuss these results, ongoing silver exploration and
    other near-term catalysts. Investors are invited to register for this
    event at:
    LINK

TORONTO, March 29, 2021 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (CSE: BNKR) (“Bunker Hill” or the “Company”) is pleased to report multiple high-grade silver mineralization results as part of its ongoing silver-focused drilling program, and through chip-channel sampling of newly accessible areas of the Bunker Hill Mine identified through the Company’s proprietary 3D digitization program.

Sam Ash, CEO of Bunker Hill, stated: “Having completed the drilling campaign designed to support the mine restart plan and associated PEA, we have now shifted our drilling and sampling focus to high-grade silver exploration in order to bring more silver into our upper mine resources and future mine planning.

Today’s results confirm high grade silver mineralization in two distinct areas of the upper mine close to existing infrastructure. Firstly, we have confirmed the silver potential of the Deadwood vein through ten separate high-grade channel samples. Secondly, our systematic targeting methodology allowed us to confirm the presence of high-grade silver mineralization on the 5-level through drilling, within an area where no historical mining was conducted. Both of these areas, along with others, will be followed up and developed over the coming weeks.”

Channel Sampling at the
9-Level Results in Ten Separate High-Grade Silver Mineralization Results

As a result of the digitization of the historic mine data and underground reconnaissance, an area was identified on the 9-level with access to the Deadwood vein: a shallow dipping galena-quartz (“GQ”) silver-lead vein that was mined until mine closure. The vein is exposed in the footwall rib of an historic stope over roughly 35 feet horizontally, with the thickness of mineralized exposure ranging from roughly 1 to 2 meters. Chip samples were collected from 10 vertical channels on the footwall rib designed to approximately crosscut the strike of the vein. See Figure 1 showing the sample distribution and resulting grades.

Digitization and reconnaissance efforts indicate that silver-lead mineralization from the Deadwood vein remains open to testing up-dip, down dip and along strike to the west. Follow up diamond drilling is planned to test the extent of the Deadwood vein and nearby Jersey vein, another historically mined GQ silver-lead vein on the 9 Level of the mine.

______________________________
1 Prices used to calculate Ag Eq are as follows: Zn=$1.16/lb; Pb=$0.92/lb; and Ag=$20/oz.

Figure 1: 090-23-21 Deadwood
Vein Stope – Floor 4 Footwall Rib Channel Samples

https://www.globenewswire.com/NewsRoom/AttachmentNg/6e30b1cd-59c5-4713-95c4-84a9328e8c8a

Channel sample assays results are presented in the Table 1 below.

TABLE 1: CHANNEL SAMPLE ASSAYS

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

1

0

0.9

0.9

317.5

56.8

8.2

0

0.9

2.1

1.2

135.1

4

4.1

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

2

0

1.2

1.2

1156.7

497

20.9

0

1.2

2.4

1.2

69.4

4.4

2.1

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

3

0

0.6

0.6

1022.2

312

22.5

0

0.6

1.2

0.6

1618.9

940

21.5

0

1.2

1.8

0.6

161.2

21.6

4.4

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

4

0

1.2

1.2

955

336

19.6

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

5

0

1.2

1.2

412.4

96

10

0

1.2

2.1

0.9

1199.6

549

20.6

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

6

0

0.9

0.9

1228.7

581

20.5

0

0.9

1.8

0.9

1054.2

377

21.4

0.1

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

7

0

1.2

1.2

737

206

16.8

0

1.2

2.1

0.9

901

288

19.4

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

8

0

0.9

0.9

49.2

2.5

1.4

0.1

0.9

1.8

0.9

975.1

343

20

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

9

0

0.6

0.6

85.7

17.3

2.2

0

0.6

1.2

0.6

3002.6

1100

60.3

0

Channel

From

To

M

AgEq g/t

g/t Ag

%Pb

%Zn

10

0

0.6

0.6

21.3

2.6

0.6

0

0.6

1.5

0.9

40.1

20.3

0.6

0

(Reported widths are actual
sampled interval lengths and do not state the true width of the mineralized
structure. Samples were taken in a manner to reflect, as closely as possible,
true structural width. Prices used to calculate AgEq are as follows: Zn=$1.16/lb;
Pb=$0.92/lb; and Ag=$20/oz.)

Drilling at the 5-Level
Results in Nearly 4-Meter Intercept at Approximately 1,000 g/t AgEq

Concurrently, drilling from the 5-level UTZ intersected high-grade silver-lead-zinc mineralization below the UTZ fingers zone, as part of exploring for near-surface silver targets. The Company is excited to report a 3.8m intercept with a grade of 996.6 g/t AgEq, as indicated in Table 2 below. Intercepted mineralization in hole 7069 (see Figure 2 below showing cross-section and Figure 3 below showing drill core) lies near existing rehabilitated infrastructure, providing low-cost access to the zone for mining under Bunker Hill’s Phase 1 program of the Rapid Restart Plan. Follow up drilling will explore the extent of the mineralization and increase the understanding of the geology in the area.

The drill results in the table below represent the most recent assay data available since the Company’s news release dated February 26, 2021; the Company will continue to report mineralized drill intercepts concurrent with its ongoing exploration program that is currently envisaged to comprise 10,000 to 12,000 feet in 2021.

TABLE 2: HIGH-GRADE SILVER
INTERCEPT FROM HOLE 7069

7069

From

To

M

AgEq

g/t Ag

%Pb

%Zn

44.5

48.3

3.8

996.6

197

21.2

2.7

Including

45.7

46.3

0.6

706.5

164

15.3

1.5

46.3

47.2

0.9

1491.7

350

28.6

5.9

47.2

48.3

1.1

1462.0

310

31.8

3.7

 

7069

From

To

M

AgEq

g/t Ag

%Pb

%Zn

52.4

53.3

0.9

755.3

160

15.9

2.3

(Reported widths are
intercepted ore lengths and not true widths, as relationships with intercepted
structures and contacts vary. Prices used to calculate AgEq are as follows:
Zn=$1.16/lb, Pb=$0.92/lb, Ag=$20/oz.)

Figure 2: Cross section of
hole 7069

https://www.globenewswire.com/NewsRoom/AttachmentNg/11b3bb0c-606c-478d-ab42-22e391a9ecb8

Figure 3: Drill Core from
hole 7069

https://www.globenewswire.com/NewsRoom/AttachmentNg/057e8c21-a292-4690-aef4-4209f48e9b08

The preliminary economic assessment (“PEA”), aimed at assessing the mine’s rapid restart potential, remains on track to be published in early Q2 2021.

WEBINAR

Bunker Hill will host a
webinar to discuss the Company’s recent results and future exploration plans.
The webinar will take place on Wednesday, March 31 at 8:00 am PT/11:00am
EST. Management will be available to answer questions following the
presentation.

To join the webinar,
register from this link (also includes dial-in instructions):

Link: UPCOMING EVENTS

Adelaide Capital Idaho Conference
April 8, 2021 @ 12:00pm ET – 4:00pm ET
Join Us:
REGISTER NOW

World Gold Forum
April 13-15, 2021
https://www.worldgoldforum.com/

HC Wainwright Mining Conference

April 19-20, 2021
Join Us: REGISTER NOW

121 Mining Investment Americas
April 27-29, 2021
https://www.weare121.com/121mininginvestment-new-york/

TECHNICAL INFORMATION

Chip-channel samples were collected by hand using hammer and chisel perpendicularly across exposed mineralized structures to best represent the true width and nature of the material present. Sample collar locations were surveyed using modern survey techniques to provide positioning of each sample in three-dimensional space. Bunker Hill followed standard quality assurance/quality control (“QA/QC”) practices to ensure the integrity of samples through collection, preparation and delivery of samples to the lab. All sample locations have been photographed, with channel traces spray painted to indicate the location and orientation of each sample. Standards of certified reference materials, field duplicates and blanks were inserted as samples shipped with the chip samples to the lab.

The diamond drilling program used HQ-size core. Bunker Hill followed standard QA/QC practices to ensure the integrity of the core and sample preparation through delivery of the samples to the assay lab. The drill core was stored in a secure facility, photographed, logged, split into halves and sampled based on lithologic and mineralogical interpretations. Standards of certified reference materials, field duplicates and blanks were inserted as samples shipped with the core samples to the lab.

American Analytical Services (“AAS”) was used to provide analytical services and all results comply with both National Instrument 43-101 – Standards of Disclosure for
Mineral Projects
(“NI 43-101”) and industry standards. AAS holds an industry standard ISO 17025:2005 accreditation, specifying general requirements for laboratory performance. AAS is independent from Bunker Hill.

QUALIFIED PERSON

Mr. Scott E. Wilson, CPG, President of Resource Development Associates Inc. and a consultant to the Company, is an independent qualified person as defined by NI 43-101 and is acting as the qualified person for the Company. He has reviewed and approved the technical information summarized in this news release.

ABOUT BUNKER HILL MINING CORP.

Under new Idaho-based leadership, Bunker Hill Mining Corp. intends to sustainably restart and develop the Bunker Hill Mine as the first step in consolidating a portfolio of North American precious-metal assets with a focus on silver. Information about the Company is available on its website, www.bunkerhillmining.com, or under the Company’s profile on SEDAR at www.sedar.com and on EDGAR at www.sec.gov.

For additional information contact:

Sam Ash, President and Chief Executive Officer
+1 208 786 6999
sa@bunkerhillmining.com

CAUTIONARY STATEMENTS

Certain statements in this news
release are forward-looking and involve a number of risks and uncertainties.
Such forward-looking statements are within the meaning of that term in Section
27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, as well as within the meaning of
the phrase ‘forward-looking information’ in the Canadian Securities
Administrators’ National Instrument 51-102 – Continuous Disclosure Obligations.
Forward-looking statements are not comprised of historical facts.
Forward-looking statements include estimates and statements that describe the
Company’s future plans, objectives or goals, including words to the effect that
the Company or management expects a stated condition or result to occur.
Forward-looking statements may be identified by terminology such as “may”,
“will”, “could”, “should”, “expect”, “plan”, “anticipate”, “believe”, “intend”,
“estimate”, “projects”, “predict”, “potential”, “continue” or other similar
expressions concerning matters that are not historical facts.

Since forward-looking
statements are based on assumptions and address future events and conditions,
by their very nature they involve inherent risks and uncertainties. Although
these statements are based on information currently available to the Company,
the Company provides no assurance that actual results will meet management’s
expectations. Risks, uncertainties and other factors involved with
forward-looking information could cause actual events, results, performance,
prospects and opportunities to differ materially from those expressed or
implied by such forward-looking information. The key risks and uncertainties
include, but are not limited to: local and global political and economic
conditions; governmental and regulatory requirements and actions by
governmental authorities, including changes in government policy, government
ownership requirements, changes in environmental, tax and other laws or
regulations and the interpretation thereof; developments with respect to the
coronavirus disease 2019 (“COVID-19”) pandemic, including the duration,
severity and scope of the pandemic and potential impacts on mining operations;
and other risk factors detailed from time to time in the Company’s reports
filed on SEDAR and EDGAR.

Forward-looking information
and statements in this news release include statements concerning, among other things:
the Company’s intention to conduct follow up drilling to test the extent of the
Deadwood vein and nearby Jersey vein; the Company’s intention to conduct follow
up drilling from the 5-level of the mine to explore the extent of the
mineralization and increase the understanding of the geology in the area; the
timing for publishing the PEA aimed at assessing the mine’s rapid restart
potential; and the Company’s intentions regarding its objectives, goals or
future plans and statements. Factors that could cause actual results to differ
materially from such forward-looking information include, but are not limited
to: the ability to predict and counteract the effects of COVID-19 on the
business of the Company, including but not limited to the effects of COVID-19
on the price of commodities, capital market conditions, restriction on labor
and international travel and supply chains; failure to identify mineral
resources; failure to convert estimated mineral resources to reserves; the
inability to complete a feasibility study which recommends a production
decision; the preliminary nature of metallurgical test results; delays in
obtaining or failures to obtain required governmental, environmental or other
project approvals; political risks; changes in equity markets; uncertainties
relating to the availability and costs of financing needed in the future; the
inability of the Company to budget and manage its liquidity in light of the
failure to obtain additional financing, including the ability of the Company to
complete the payments pursuant to the terms of the agreement to acquire the
Bunker Hill Mine Complex; inflation; changes in exchange rates; fluctuations in
commodity prices; delays in the development of projects; capital, operating and
reclamation costs varying significantly from estimates and the other risks
involved in the mineral exploration and development industry; and those risks
set out in the Company’s public documents filed on SEDAR and EDGAR. Although
the Company believes that the assumptions and factors used in preparing the
forward-looking information in this news release are reasonable, undue reliance
should not be placed on such information, which only applies as of the date of
this news release, and no assurance can be given that such events will occur in
the disclosed time frames or at all. The Company disclaims any intention or
obligation to update or revise any forward-looking information, whether as a
result of new information, future events or otherwise, other than as required
by law. No stock exchange, securities commission or other regulatory authority
has approved or disapproved the information contained herein.


Source: Bunker Hill Mining

Release lineage cell therapeutics lctx vitelliform maculopathy patient treated with opregen under named patient compassionate use

 


Lineage Cell Therapeutics Announces Vitelliform Maculopathy Patient Treated With OpRegen® Under Named Patient Compassionate Use

 

CARLSBAD, Calif.–(BUSINESS WIRE)–Mar. 29, 2021–

Lineage Cell Therapeutics, Inc.

(NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell transplants for serious medical conditions, today announced that a patient suffering from adult-onset vitelliform macular dystrophy (AVMD) had recently been treated with its lead product candidate, OpRegen, at
Hadassah-Hebrew University Medical Center in
Jerusalem, using a named patient compassionate use approval granted by the
Israeli Ministry of Health. OpRegen is an investigational cell therapy consisting of allogeneic retinal pigment epithelium (RPE) cells administered to the subretinal space and is currently being investigated in a 24-patient phase 1/2a clinical trial for the treatment of dry age-related macular degeneration (AMD) with geographic atrophy (GA).

“Lineage is pioneering a new branch of medicine, consisting of the directed differentiation and transplant of specific cell types to replace damaged or dying cells with the goal of restoring or improving function lost to injury or disease,” stated Brian M. Culley, Lineage CEO. “With OpRegen, we are transplanting new retina cells to replace old cells that were lost or damaged to disease, with a goal of providing stability or functional improvements to vision. As outlined more fully on our recent earnings call, we believe there are many potential applications of Lineage’s core technology and intend this year to demonstrate that although we currently have three clinical-stage product candidates, those assets and our underlying platform may have utility in additional settings. For example, our RPE cells may be useful for treating additional retinal diseases, such as AVMD or Stargardt’s Disease. Similarly, our spinal cord program may be applicable to other conditions characterized by demyelination, and our oncology platform may have application across many different tumor types, depending on which antigen we elect to present to the patient’s immune system.”

Mr. Culley continued, “In this first instance, we treated a patient with AVMD, because it closely resembles dry AMD and similarly involves impaired RPE function and progressive vision loss. When the team at Hadassah approached us about treating their existing AVMD patient with OpRegen on a compassionate use basis, we were supportive of the request and saw it as an opportunity to investigate a new application for our OpRegen product candidate.”

This patient presented to the
Department of Ophthalmology at
Hadassah-Hebrew University Medical Center in late
December 2020 with sudden and severe visual acuity decreases in one eye. BCVA in the worse vision eye was measured at 20/200, compared to 20/40 in the patient’s contralateral eye. After an onset of blurred vision in 2018, evaluation and imaging diagnosed the patient as suffering from AVMD. Because AVMD is a disease of impaired RPE function leading to atrophy and shares similar characteristics to dry AMD, the team at Hadassah approached Lineage about the potential to treat this patient on a compassionate use basis. Lineage submitted a request on behalf of
Hadassah-Hebrew University Medical Center which was approved by the
Israeli Ministry of Health. Following approval from the University’s Ethics Committee, the patient was treated in
February 2021. The delivery of OpRegen RPE cells via pars plana vitrectomy was successful, with no complications arising during the procedure and the patient remains in follow-up.

About Adult-onset Vitelliform Maculopathy (AVMD)

AVMD is an eye disorder that can cause progressive vision loss and usually begins after age 40. AVMD affects an area of the retina called the macula, which is responsible for sharp central vision. The condition causes a fatty yellow pigment to accumulate in cells underlying the macula, eventually damaging the cells. Some people remain without symptoms throughout their life while others may slowly develop blurred and/or distorted vision, that can progress to central vision loss over time. There is currently no effective treatment for vitelliform macular dystrophy.

About OpRegen

OpRegen is currently being evaluated in a Phase 1/2a open-label, dose escalation safety and efficacy study of a single injection of human retinal pigment epithelium cells derived from an established pluripotent cell line and transplanted subretinally in patients with advanced dry AMD with GA. The study enrolled 24 patients into 4 cohorts. The first 3 cohorts enrolled only legally blind patients with best corrected visual acuity (BCVA) of 20/200 or worse. The fourth cohort enrolled 12 better vision patients (vision from 20/65 to 20/250 with smaller areas of GA). Cohort 4 also included patients treated with a new “thaw-and-inject” formulation of OpRegen, which can be shipped directly to sites and used immediately upon thawing, removing the complications and logistics of having to use a dose preparation facility. The primary objective of the study is to evaluate the safety and tolerability of OpRegen as assessed by the incidence and frequency of treatment emergent adverse events. Secondary objectives are to evaluate the preliminary efficacy of OpRegen treatment by assessing the changes in ophthalmological parameters measured by various methods of primary clinical relevance. OpRegen is a registered trademark of
Cell Cure Neurosciences Ltd., a majority-owned subsidiary of
Lineage Cell Therapeutics, Inc.

About Lineage Cell Therapeutics, Inc. 

Lineage Cell Therapeutics
is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Lineage’s clinical programs are in markets with billion dollar opportunities and include three allogeneic (“off-the-shelf”) product candidates: (i) OpRegen®, a retinal pigment epithelium transplant therapy in Phase 1/2a development for the treatment of dry age-related macular degeneration, a leading cause of blindness in the developed world; (ii) OPC1, an oligodendrocyte progenitor cell therapy in Phase 1/2a development for the treatment of acute spinal cord injuries; and (iii) VAC, an allogeneic dendritic cell therapy platform for immuno-oncology and infectious disease, currently in clinical development for the treatment of non-small cell lung cancer. For more information, please visit
www.lineagecell.com or follow the Company on Twitter @LineageCell.

Forward-Looking Statements

Lineage cautions you that all statements, other than statements of historical facts, contained in this press release, are forward-looking statements. Forward-looking statements, in some cases, can be identified by terms such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “design,” “intend,” “expect,” “could,” “plan,” “potential,” “predict,” “seek,” “should,” “would,” “contemplate,” project,” “target,” “tend to,” or the negative version of these words and similar expressions. Such statements include, but are not limited to, statements relating to the potential conditions and diseases applicable to Lineage’s clinical-stage product candidates. Forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause Lineage’s actual results, performance or achievements to be materially different from future results, performance or achievements expressed or implied by the forward-looking statements in this press release, including risks and uncertainties inherent in Lineage’s business and other risks in Lineage’s filings with the
Securities and Exchange Commission (SEC). Lineage’s forward-looking statements are based upon its current expectations and involve assumptions that may never materialize or may prove to be incorrect. All forward-looking statements are expressly qualified in their entirety by these cautionary statements. Further information regarding these and other risks is included under the heading “Risk Factors” in Lineage’s periodic reports with the
SEC, including Lineage’s most recent Annual Report on Form 10-K filed with the
SEC
and its other reports, which are available from the SEC’s website. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date on which they were made. Lineage undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as required by law.

Lineage Cell Therapeutics, Inc. IR
Ioana C. Hone
(ir@lineagecell.com)
(442) 287-8963

Solebury Trout IR
Gitanjali Jain Ogawa
(Gogawa@troutgroup.com)
(646) 378-2949

Russo Partners – Media Relations
Nic Johnson or David Schull
Nic.johnson@russopartnersllc.com
David.schull@russopartnersllc.com
(212) 845-4242

Source: Lineage Cell Therapeutics, Inc.

Research coverage of Lineage Cell Therapeutics (LCTX) on Channelchek is provided by Noble Capital Markets, Inc. Please refer to the research disclosures on the most recent LCTX report for more information.

Do Robinhood Investors Make Money?

 


Reddit, Robinhood, and Rocketships

 

Playgrounds aren’t only for the young. They’re also used by older adults to sit, watch and remember when they were at an age when they barely concerned themselves with bumps, cuts, and bruises that are part of a good day of play. Last year and continuing into 2021, the U.S. stock market has become a playground of sorts to many younger investors. While much has been written that scoffs at the carefree attitude of the subreddit WallStreetBets, Robinhood, and rocket emoji users, perhaps those sneering overlook the benefits the trading app investor is getting from their interaction with the markets and each other. The newest investor class is gaining respect, recognition, and legitimacy among traders and investors of more traditional styles.

Winning
Percentage

Staying with the playground theme; imagine it’s Sunday morning, you’ve finished going through overnight emails, just read today’s Channelchek article, and now decide to walk over to the park. You check your favorite weather app, and it reads there is a 5% chance of rain. Do you dare go out? Is it smarter to skip the potential reward of activities in the park that have been given a 5% chance of being ruined and instead stay inside so you don’t run the risk of being rained on? After all, on days like this, there is only a 95% chance that it will turn out well.

Please excuse my sarcasm, but over the past 12 months, 5% is the statistic of companies that are part of the broad Wilshire 5000 that finished 12 months ending March 23, in the red. Looking back, that was the chance of having picked a bad U.S. headquartered company stock, 5% or one in twenty.  In fact, I understated the percentage, actually, 95.9% of the 3000+ stocks in the Wilshire 5000 index had a positive return from a year ago (4.1% were not positive). The only other 12- month period that comes close was in 2004 when 93% had a positive return.  I used the Wilshire 5000 because it’s a much more inclusive, broader measure than other more reported on indexes. This makes it better for gauging the price performance of American publicly traded U.S. companies.

Chicken
Little (The Sky is Falling)

Is anyone served if someone is at the park and warning those happily playing that there’s a 5% chance of rain? Or should those benefitting from the still positive environment be left to play until the odds noticeably change? They may have forgotten that it sometimes rains? A better approach is, if there’s a long streak of fair weather, capitalize on it until there’s a change in the air. Perfect performance doesn’t exist, but we’re in a period that is experiencing as close to it as we’ve ever seen. Whatever the reason, it doesn’t much matter, even Jesse Livermore,  who is considered the greatest trader that ever lived said, “The market is always right.” 

One derisive comment often heard in market reports or posted online is that  “…Robinhood traders are a bunch of kids living with their parents wasting their stimulus checks in the market like it’s a game.” The CARES Act was signed into law one year ago on March 27th. By mid-April, a large percentage of the first $1,200 paid would have been in the accounts of individuals. If this is part of what helped fund or add fuel to this group’s transactions, the timing was fantastic. Luck, skill, or serendipity, doesn’t matter, a large portion of the population that may never have considered any kind of investing, are now active and learning more than they otherwise would have. Certainly, market conditions will one day be negative, and most periods will be weaker than they have been, but those bumps and bruises will be the price of education, social interaction, taking chances, and even play.  

Robinhood
(High App-titude Traders)

I use the term Robinhood investors to include all trading app and online platform users that have only become active during the past five or six years amidst a period of above-average market return  – all relatively newcomers to stock buying/selling that by conventional judgment (and often their own open assessment) are doing everything wrong, yet doing pretty good. The investors/traders that post that they have no idea what they’re doing or ask the most basic questions in public forums often have remarkably good performance. The ranks of this investor class have grown substantially. There is no formal name for this group, so Robinhood is the generic moniker often used. I like to refer to them as high app-titude traders (HATs).  

The growth of this group since the advent of commission-free trades has been phenomenal. Using account growth from broker Robinhood alone, there have been years where the size has doubled and tripled.

 

 

Below we see the average dollar size of the accounts are small, so in reality, high-levels of concern for their “gambling” may be misplaced. The amount they can lose (w/o margin) is not reckless. As a group, they may not know much about stocks but they are savvy and learning.

 

 

The average Robinhood user age is 31 years old, which means most began school after the internet became widely used in homes. Many are adept at online games played on their smartphone or desktop. This may even give them an advantage not appreciated by those who learned while having to dial their broker from a landline.

 

 

Take-Away

Playground visitors practice and hone important skills. If the Robinhood style investors are treating the market like a playground, they are likely learning through their own play. This by far is more mass investment education being obtained than by any group of young adults that came before them. At a time when everyone is living longer, and many of those now approaching retirement are financially unprepared, education (even through play), with smaller sums of money, may become extremely positive for the future.

Any visit to the more popular subreddits, Facebook discussion groups, and even Stocktwits will reveal posts by people investing that openly declare they don’t know what they’re doing. There are throngs of account owners with their finger on the buy or sell button that solicit advice from others that they know could be even less informed. Yet many of the same inexperienced market participants or HATs declare almost daily they just made another $300 or more. The upward trending broad market has allowed them to not only stay alive but for many, actually thrive.

Why suggest newcomers stay away from the markets when the win percentage remains so high? There has never been anywhere near as positive of a win percentage at other “playgrounds” like a casino. Even most lotteries only return 65% to very few players. Both of these activities are accepted because we know play is its own reward. Stock trading is just as legitimate with limits.

In the case of today’s newest market participants, huge by comparison to those in their age group at any time in the past, they are becoming accustomed to being active in the stock market. This could help them.  For many, the most valuable lessons will come when the market is no longer repaying on such a high percentage of positions. When that occurs, we’ll have over 13 million, who on average have invested the same amount as they’d have invested on a couple of three-credit classes at a U.S. University. That’s very cheap for a hands-on real-world financial market education.

 Paul Hoffman

Managing Editor, Channelchek

Suggested Reading:

Stimulus Checks, Taxes, and Investments

Understanding the Robinhood Class Action Lawsuit


Will Robinhood be Sued for Gamification?

What is an ESG Score?

 

Sources:

https://www.investopedia.com/articles/basics/09/compare-investing-gambling.asp

https://en.wikipedia.org/wiki/Jesse_Livermore

https://studentloanhero.com/featured/cost-per-credit-hour-study/

 

Stay up to date. Follow us:

           


Stay up to date. Follow us:

Why Oil Prices Could Continue Going Up

 


Are There Long-Lived Changes in Oil Markets that Hold it Above $50/bbl?

 

Oil prices have risen dramatically in recent months. The upward trend took root in November of 2020 and seems firmly in place. Oil’s current strength reflects increasing optimism for a global economic recovery as fewer cases of Covid19 lead to more petroleum-consuming activities.  While prices have gone up, producers have been slow to respond to the increase, as evidenced by continued low rig count numbers. These factors provide investors hope that there has been a fundamental change to the supply and demand of oil that could lead to oil prices staying above $50/bbl.  The below graph shows the recent rise in WTI and Brent oil prices.

 

 

Is Backwardation a Concern?

The upward trend in oil prices accelerated in March as OPEC unexpectedly held supply reduction levels despite growing demand. Spot prices have jumped again in recent days with the news that a container ship was blocking the Suez Canal and could take weeks to free. These two events have moved spot and futures prices higher, but not evenly. At current levels, spot prices are higher than future prices, a situation referred to as backwardation (see chart below). When near-term prices are below long-term prices, that situation is referred to as contango.

 

 

Higher spot prices relative to longer-term contracts is often a sign that prices are expected to fall. This is often the case when spot prices have risen due to events that are seen as temporary (OPEC decisions and Suez Canal Blockage) as opposed to events that may be longer-term in nature (Increased drilling, changing economic conditions, technological breakthroughs, etc.)  Futures curve backwardation is not unusual. However, the current spread between near-term and longer-term prices is unusually large. The chart below shows how the spread has been growing over the last twelve months.

 

 

Take-Away

A futures curve is by no means a perfect predictor of the direction of oil prices. However, it can give investors insight into other investor expectations. And, of course, the futures curve tells us something about what price might be received by energy producers seeking to hedge production. Investors should make sure to monitor all oil pricing when deciding whether to buy an energy stock and not just the spot price.

Suggested Reading:


Uranium is an ESG Energy Source Getting More Attention Private Energy Companies Role in Energy Cycle



Ruling Out Nuclear Energy Now Could be a Mistake Energy 2020-4Q Review and Outlook

 

C-Suite Series: enCore Energy (ENCUF)(EU.V) CEO Paul Goranson
& Exec. Chairman William Sheriff

  • Outlook for uranium pricing; how enCore’s production capabilities position them well for the next big move
  • Supply and demand outlook for uranium; value of building a strategic reserve
  • Steps they’ve taken to restart the processing plants acquired in 2020
  • Long term plans for existing assets in New Mexico; addressing environmental & community standards in restarting activities
  • Current cash position; plans to finance future growth

Watch The Video

 

Sources:

https://finance.yahoo.com/news/low-tide-slows-clear-suez-033034022.html, Yusri Modamed, Gavin Maguire and Florence Tan, Reuters, March 24, 2021

https://www.eia.gov/outlooks/steo/marketreview/crude.php, EIA, March 9, 2021

https://www.reuters.com/article/uk-global-oil-idUSKBN2B001L, Laura Sanicola, Reuters, March 7, 2021

Release – One Stop Systems (OSS) – Reports Q4 2020 Revenue

 


OSS Reports Q4 2020 Revenue up 7% over Q3 to $13.9 Million, Net Income of $244,000 or $0.01 per Share

 

ESCONDIDO, Calif., March 25, 2021 (GLOBE NEWSWIRE) — One Stop Systems, Inc. (Nasdaq: OSS), a leader in specialized high-performance edge computing, reported results for the fourth quarter and full year ended December 31, 2020.

Q4 Financial Highlights

  • Revenue in the fourth quarter of 2020 totaled $13.9 million, up 7% from Q3 2020, and lower by 24% versus the same year-ago quarter due to COVID-19-related issues.
  • Operating expenses in the fourth quarter of 2020 decreased 9% from the year-ago quarter to $4.3 million.
  • Net income on a GAAP basis totaled $244,000 or $0.01 per share.
  • Cash and cash equivalents totaled $6.3 million on December 31, 2020, up from $5.5 million on September 30, 2020. Earlier this month the company raised net proceeds of approximately $9.3 million via a registered direct offering, resulting in current cash of about $19 million.

Full Year 2020 Financial Highlights

  • Revenue totaled $51.9 million.
  • Operating expenses decreased 16% to $16.9 million. This reduction in operating expenses by more than $3.3 million includes the prior year’s charge of $1.7 million for goodwill impairment which was recorded in Q2 2019. On a proforma basis, after eliminating the effect of the prior year impairment charge, operating expenses were reduced by $1.6 million.
  • Loss from operations decreased to $424,000 compared to a loss of $779,000 in the prior year. After giving effect to the goodwill impairment charge described above, loss from operations increased $1.3 million.
  • Net loss on a GAAP basis for the full year of 2020 totaled $6,500 or $(0.00) per basic and diluted share, as compared to a net loss of $0.9 million or $(0.06) per basic and diluted share.
  • Non-GAAP net income for the full year of 2020 totaled $1.4 million or $0.08 per share, compared to non-GAAP net income of $2.3 million or $0.14 per diluted share.

2020 Operational Highlights

  • New program wins continued at a strong pace despite the pandemic. For 2020, the company won 16 new $1 million-plus programs, with 10 representing new customers.
  • The new program wins in 2019 and 2020 yielded $18 million of revenue for 2020, with $12 million generated by new customers. This diversification has reduced OSS’ dependency on its top two customers, which represented 25% of the company’s total business in 2020 compared to 41% in 2019.
  • Awarded fourth major program win by the company’s second largest customer, a large military prime contractor.
  • Company’s first-to-market PCI Express Gen 4 products generated more than $6.0 million in revenue. Applications included autonomous vehicles, military, and instrumentation.
  • Appointed technology industry veteran, David Raun, as president and CEO. (Q2)
  • Added three new independent board members while supporting gender and ethnic diversity. (Q3)
  • Completed reorganization with focus on long-term strategic vision, stronger margins, and enhancing shareholder value. This included the implementation of an expense reduction program. Savings from this effort are estimated to be $2.5 million on an annual basis. (Q2)

2020 Product and Technology Highlights

  • Introduced PCI Express Gen 4 compute accelerator incorporating the NVIDIA V100S Tensor Core GPU, thereby delivering data center capabilities to HPC and AI deployments at the edge. (Q1)
  • First-to-market with NVIDIA’s latest A100 Tensor Core GPU in an OSS upgraded compute accelerator, boosting performance by 20x over the previous generation. (Q2)
  • Introduced a new 4U Pro PCI Express Gen 4 expansion platform for edge, AI Transportables™ applications. (Q4)

Q4 Financial Summary

Revenue in the fourth quarter of 2020 totaled $13.9 million, up 7.4% from $13.0 million in the previous quarter. The sequential improvement in the fourth quarter of 2020 was due to increased sales to the company’s two largest accounts and new customers.

On a quarterly year over year basis, revenue was lower by 24.4% compared to $18.4 million in the same year-ago quarter. The decrease compared to the year-ago quarter was primarily due to pandemic driven reductions.

Gross profit was $4.8 million or 34.5% of revenue, which decreased by one percentage point from 35.5% in Q4 2019. The decrease was attributed to $4.5 million less in revenue in Q4 2020 and a higher mix of Bressner sales in Q4 2019.

Operating expenses decreased 9.2% to $4.3 million compared to $4.7 million in the same year-ago quarter. Operating expenses as a percentage of revenue increased to 30.9% in the fourth quarter of 2020 versus 25.7% in the year-ago quarter. The increase was primarily attributable to lower revenue.

Net income on a GAAP basis totaled $244,000 or $0.01 per basic and diluted share compared to a net income of $1.1 million or $0.06 per diluted share in the year-ago period.

Non-GAAP net income totaled $636,000 or $0.04 per share, as compared to $1.3 million or $0.07 per diluted share in the same year-ago period.

Adjusted EBITDA, a non-GAAP term, totaled $1.1 million as compared to $2.4 million in the same year-ago period.

Cash and cash equivalents totaled $6.3 million as of December 31, 2020, as compared to $5.5 million at September 30, 2020. Current cash on hand totals approximately $19 million after a registered direct offering for net proceeds of approximately $9.3 million completed earlier this month. The company believes its cash position and other available funds provides sufficient liquidity to meet its cash requirements for working capital and paying down debt, while also supporting the company’s growth and strategic initiatives.

Full Year 2020 Financial Summary

For the full year of 2020, revenue was $51.9 million, a decrease of 11% from $58.3 million in the same year-ago period. The decrease was primarily due to the impact of COVID-19.

Gross profit was $16.4 million or 31.7% of revenue, compared to $19.4 million or 33.3% of revenue in 2019.

Operating expenses decreased 16.5% to $16.9 million from $20.2 million in 2019. Operating expenses as a percentage of revenue improved to 32.5% versus 34.6% in the year-ago period. The decrease in operating expense is largely attributable to the company’s expense reduction program, less the goodwill impairment charge of $1.7 million in the prior year.

Net loss on a GAAP basis totaled $6,500 or $(0.00) per share, as compared to a loss of $900,000 or $(0.06) per share in 2019.

Non-GAAP net income totaled $1.4 million or $0.08 per share, as compared to non-GAAP net income of $2.3 million or $0.14 per diluted share in the full year of 2019.

Adjusted EBITDA, a non-GAAP term, was $1.8 million, as compared to $3.2 million in 2019.

Management Commentary

“In 2020 we seized the opportunity to take several transformative steps and have laid the cornerstones for a stronger foundation on which to build our future growth,” commented OSS president and CEO, David Raun. “These steps included new senior leadership and corporate reorganization, reduced spending, three new independent board members, which also added to our board diversity, and we directed more focus on our long-term strategic vision to increase shareholder value over time.

“Regarding our financials, we are pleased to announce that we were able to exceed our Q4 2020 revenue outlook by about $900,000. This was a direct result of our continued efforts to drive existing OEM business and our success in expanding our customer base, offsetting some of the downside from the pandemic.

“We see early indications of improvements with customers impacted by COVID. While we anticipate the impact will continue for some time in 2021, our energies are focused on a return to normalcy and the opportunities inherent in that improved environment.

“As previously stated, the pandemic impacted our top-line revenue growth in 2020 with several of our key customers. We identified about $14 million in lost or delayed revenue compared to our annual plan due to COVID-related matters.

“More than half of the lost or delayed revenue in 2020 was from our largest customer in the media and entertainment industry. During the fourth quarter we saw an encouraging rebound by this customer, as their 3D virtual product line continues to develop traction in the market.

“Their product premiered last year on American Idol as the virtual performance stage in a Katy Perry music video. We expect their virtual platform to drive increased sales in the current and future quarters. The eventual return of live events should contribute additional revenue from their core products in the second half of the year.

“Earlier this month, we announced a direct offering which further fortified our cash position. In addition to the offering, we achieved significant cash gains through a combination of lower expenses, increased efficiency, and improvements in working capital. The result is that we currently have a cash position of approximately $19 million. This gives us the ability to invest in key strategic initiatives that should fuel future growth.

“During the fourth quarter of 2020, we closed four additional major OEM opportunities, including two industrial, one instrumentation and one autonomous driving project. For 2020, the program wins totaled 16, which matched 2019 without the pandemic. As a reminder, we define program wins as those expected to yield $1 million or more of revenue within four years. Our 32 program wins over the past two years contributed $18 million to 2020 revenue, including $12 million from new customers supporting our diversification initiatives.

“We have defined and started implementation of a multi-year strategic plan to enhance our product road map, market position and value proposition for target industries and customers. After confidential discussions with customers, much research, trend analysis, review of core strengths and our current business, we have identified a focus segment within the fast-growing edge computing space.

“Our strategic focus is on a quickly developing segment of edge computing. We call it AI Transportables. This includes anything that is not in a fixed location but requires the very latest in high-performance computing for AI where responsive action needs to be taken immediately at the very edge.

“The challenges associated with these AI Transportables is where OSS core capabilities and expertise is strongest, and we believe will offer the greatest growth opportunities. We look forward to sharing additional details on our quarterly conference call later today and in future communications.

“While there remains uncertainty around when we will finally conquer the pandemic and return to business as usual, we believe the worst is now behind us. We see signs of improvement, and OSS has become foundationally stronger to execute its strategic plan and create increasing value for our shareholders.”

Outlook
For the first quarter of 2021, OSS expects revenue of approximately $13 million.

Conference Call
OSS management will hold a conference call to discuss its fourth quarter and full year 2020 results later today, followed by a question-and-answer period.

Date: Thursday, March 25, 2021
Time: 5:00 p.m. Eastern time (2:00 p.m. Pacific time)
Toll-free dial-in number: 1-800-437-2398
International dial-in number: 1-786-204-3966
Conference ID: 1791479

The conference call will be webcast live and available for replay here as well as via a link in the Investors section of the company’s website at ir.onestopsystems.com. OSS regularly uses its website to disclose material and non-material information to investors, customers, employees and others interested in the company.

Please call the conference telephone number five minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact CMA at 1-949-432-7566.

A replay of the call will be available after 8:00 p.m. Eastern time on the same day through April 8, 2021.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 1791479

About One Stop Systems
One Stop Systems, Inc. (OSS) designs and manufactures innovative specialized high-performance edge computing modules and systems, including customized servers, compute accelerators, expansion systems, flash storage arrays and Ion Accelerator storage software. These products are used for deep learning, AI, defense, finance, and entertainment applications, and empower scientists, engineers, creators and other professionals to push the boundaries of their industries.

OSS utilizes the power of PCI Express, the latest GPU accelerators and NVMe storage to build award-winning systems, including many industry firsts, for OEMs and government customers. The company enables AI on the Fly® by bringing AI datacenter performance to ‘the edge’ and on mobile platforms, and by addressing the entire AI workflow, from high speed data acquisition to deep learning, training and inference. OSS products are available directly or through global distributors. For more information, go to www.onestopsystems.com.

Non-GAAP Financial Measures
Management believes that the use of adjusted earnings before interest, taxes, depreciation and amortization, or adjusted EBITDA, is helpful for an investor to assess the performance of the company. The company defines adjusted EBITDA as income (loss) attributable to common stockholders before interest, taxes, depreciation, amortization, acquisition expense, impairment of long-lived assets, financing costs, fair value adjustments from purchase accounting, stock-based compensation expense and expenses related to discontinued operations.

Adjusted EBITDA is not a measurement of financial performance under generally accepted accounting principles in the United States, or GAAP. Because of varying available valuation methodologies, subjective assumptions and the variety of equity instruments that can impact a company’s non-cash operating expenses, management believes that providing a non-GAAP financial measure that excludes non-cash and non-recurring expenses allows for meaningful comparisons between the company’s core business operating results and those of other companies, as well as providing the company with an important tool for financial and operational decision making and for evaluating its own core business operating results over different periods of time.

The company’s adjusted EBITDA measure may not provide information that is directly comparable to that provided by other companies in its industry, as other companies in the company’s industry may calculate non-GAAP financial results differently, particularly related to non-recurring and unusual items. The company’s adjusted EBITDA is not a measurement of financial performance under GAAP, and should not be considered as an alternative to operating income or as an indication of operating performance or any other measure of performance derived in accordance with GAAP. Management does not consider adjusted EBITDA to be a substitute for, or superior to, the information provided by GAAP financial results.

                 
    For the Three Months Ended December 31,   For the Year Ended December 31,
      2020       2019       2020       2019  
Net loss attributable to common stockholders   $ 243,860     $ 1,094,126     $ (6,544 )   $ (900,337 )
Depreciation and amortization     397,770       415,104       1,606,532       1,655,288  
Amortization of deferred gain           (12,359 )     (53,838 )     (28,555 )
Impairment of goodwill                       1,697,394  
Stock-based compensation expense     220,959       159,329       724,378       649,469  
Interest income     (150,468 )     (25,266 )     (418,379 )     (151,113 )
Interest expense     157,599       54,097       550,774       165,560  
Costs resulting from dissolution of SkyScale           (146,150 )           (146,150 )
Acquisition expenses                       4,075  
(Benefit) provision for income taxes     247,312       832,142       (603,744 )     237,252  
Adjusted EBITDA   $ 1,117,032     $ 2,371,023     $ 1,799,179     $ 3,182,883  
                 

Adjusted EPS excludes the impact of certain items and, therefore, has not been calculated in accordance with GAAP. Management believes that exclusion of certain selected items assists in providing a more complete understanding of the company’s underlying results and trends and allows for comparability with its peer company index and industry. Management uses this measure along with the corresponding GAAP financial measures to manage the company’s business and to evaluate its performance compared to prior periods and the marketplace. The Company defines non-GAAP (loss) income attributable to common stockholders as (loss) or income before amortization, stock-based compensation, expenses related to discontinued operations, and acquisition costs. Adjusted EPS expresses adjusted (loss) income on a per share basis using weighted average diluted shares outstanding.

Adjusted EPS is a non-GAAP financial measure and should not be considered in isolation or as a substitute for financial information provided in accordance with GAAP. These non-GAAP financial measures may not be computed in the same manner as similarly titled measures used by other companies. Management expects to continue to incur expenses similar to the adjusted income from continuing operations and adjusted EPS financial adjustments described above, and investors should not infer from our presentation of these non-GAAP financial measures that these costs are unusual, infrequent or non-recurring.

The following table reconciles net loss attributable to common stockholders and diluted earnings per share:

                 
    For The Three Months Ended December 31,   For the Year Ended December 31,
      2020       2019       2020       2019  
Net loss attributable to common stockholders   $ 243,860     $ 1,094,126     $ (6,544 )   $ (900,337 )
Amortization of intangibles     170,985       174,525       683,935       984,065  
Impairment of goodwill                       1,697,394  
Stock-based compensation expense     220,959       159,329       724,378       649,469  
Cost resulting from dissolution of SkyScale           (146,150 )           (146,150 )
Acquisition expenses                       4,075  
Non-GAAP net income attributable to common stockholders   $ 635,804     $ 1,281,830     $ 1,401,769     $ 2,288,516  
                 
Non-GAAP net income per share attributable to common stockholders:                
Basic   $ 0.04     $ 0.08     $ 0.08     $ 0.15  
Diluted   $ 0.04     $ 0.07     $ 0.08     $ 0.14  
Weighted average common shares outstanding:                
Basic     16,639,514       16,107,786       16,512,203       15,148,613  
Diluted     17,143,126       17,117,800       16,752,434       16,158,627  
                 

Forward-Looking Statements
One Stop Systems cautions you that statements in this press release that are not a description of historical facts are forward-looking statements. These statements are based on the company’s current beliefs and expectations. The inclusion of forward-looking statements should not be regarded as a representation by One Stop Systems or its partners that any of our plans or expectations will be achieved, including but not limited to, to our management’s expectations for revenue growth generated by new products and design wins. Actual results may differ from those set forth in this press release due to the risk and uncertainties inherent in our business, including risks described in our prior press releases and in our filings with the Securities and Exchange Commission (SEC), including under the heading “Risk Factors” in our Annual Report on Form 10-K and any subsequent filings with the SEC. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof, and we undertake no obligation to revise or update this press release to reflect events or circumstances after the date hereof. All forward-looking statements are qualified in their entirety by this cautionary statement, which is made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

Media Contact:
Katie Rivera
One Stop Systems, Inc.
Tel (760) 745-9883
Email contact

Investor Relations:
Ronald Both or Grant Stude
CMA
Tel (949) 432-7557
Email contact


ONE STOP SYSTEMS, INC. (OSS)

CONSOLIDATED BALANCE SHEETS

    December 31,   December 31,
    2020   2019
ASSETS                
Current assets                
Cash and cash equivalents   $ 6,316,921     $ 5,185,321  
Accounts receivable, net     7,458,383       11,667,157  
Inventories, net     9,647,504       7,369,356  
Prepaid expenses and other current assets     655,708       453,938  
Total current assets     24,078,516       24,675,772  
Property and equipment, net     3,487,178       3,568,564  
Deposits and other     81,709       47,146  
Deferred tax assets, net     3,698,593       3,019,823  
Goodwill     7,120,510       7,120,510  
Intangible assets, net     662,257       1,346,192  
    $ 39,128,763     $ 39,778,007  
                 
LIABILITIES AND STOCKHOLDERS’ EQUITY                
Current liabilities                
Accounts payable   $ 976,420     $ 4,115,977  
Accrued expenses and other liabilities     3,481,444       4,607,432  
Current portion of notes payable, net of debt discount of $2,047 and $7,019, respectively     1,365,204       1,377,751  
Current portion of related-party notes payable, net of debt discount of $6,726 and $23,060, respectively     199,943       561,441  
Senior secured convertible note, net of discounts of $256,242     1,789,212        
Total current liabilities     7,812,223       10,662,601  
Notes payable, net of current portion and debt discount of $0 and $2,047, respectively           149,301  
Related-party notes payable, net of current portion and debt discount of $0 and $6,726, respectively           199,943  
Senior secured convertible note, net of discounts of $14,107     531,347        
Paycheck protection plan note payable     1,499,360        
Total liabilities     9,842,930       11,011,845  
Commitments and contingencies                
Stockholders’ equity                
Common stock, $.0001 par value; 50,000,000 shares authorized; 16,684,424 and 16,121,747 shares issued and outstanding, respectively     1,668       1,612  
Additional paid-in capital     30,758,354       30,537,015  
Noncontrolling interest           500  
Accumulated other comprehensive income (loss)     287,547       (17,773 )
Accumulated deficit     (1,761,736 )     (1,755,192 )
Total stockholders’ equity     29,285,833       28,766,162  
    $ 39,128,763     $ 39,778,007  


ONE STOP SYSTEMS, INC. (OSS)

CONSOLIDATED STATEMENTS OF OPERATIONS

    For the Three Months Ended December 31,   For the Year Ended December 31,
      2020       2019       2020       2019  
Revenue   $ 13,934,365     $ 18,424,920     $ 51,895,388     $ 58,308,019  
Cost of revenue     9,122,247       11,877,357       35,460,774       38,905,756  
Gross margin     4,812,118       6,547,563       16,434,614       19,402,263  
Operating expenses:                
General and administrative     2,209,436       2,033,551       8,418,358       8,501,572  
Impairment of goodwill                       1,697,394  
Marketing and selling     982,945       1,379,861       4,120,778       5,138,762  
Research and development     1,106,420       1,320,039       4,319,759       4,843,554  
Total operating expenses     4,298,801       4,733,451       16,858,895       20,181,282  
Income (loss) from operations     513,317       1,814,112       (424,281 )     (779,019 )
Other (expense) income:                
Interest income     150,468           418,379      
Interest expense     (157,599 )     (54,096 )     (550,774 )     (165,560 )
Other (expense) income, net     (15,014 )     166,252       (53,612 )     281,494  
Total other (expense) income, net     (22,145 )     112,156       (186,007 )     115,934  
Income (loss) before income taxes     491,172       1,926,268       (610,288 )     (663,085 )
Provision (benefit) for income taxes     247,312       832,142       (603,744 )     237,252  
Net income (loss)   $ 243,860     $ 1,094,126     $ (6,544 )   $ (900,337 )
                 
Net income (loss) per share:                
Basic   $ 0.01     $ 0.07     $ (0.00 )   $ (0.06 )
Diluted   $ 0.01     $ 0.06     $ (0.00 )   $ (0.06 )
                 
Weighted average common shares outstanding:                
Basic     16,639,514       16,107,786       16,512,203       15,148,613  
Diluted     17,143,126       17,117,800       16,512,203       15,148,613  
                 

Source: One Stop Systems, Inc.